Immune Therapeutics (OTC: IMUN)
You can purchase shares of Immune Therapeutics (OTCPK: IMUN) through any online brokerage.
There are no as such competitors for Immune Therapeutics.
There is no analysis for Immune Therapeutics
The stock price for Immune Therapeutics (OTCPK: IMUN) is $1.6 last updated May 25, 2022, 4:01 PM UTC.
There are no upcoming dividends for Immune Therapeutics.
Immune Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Immune Therapeutics.
Immune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.